Research output per year
Research output per year
- 1 - 50 out of 103 results
Search results
-
2024
Clinical and Genomic Characterization of Long-Term Responders Receiving Immune Checkpoint Blockade for Metastatic Non–Small-Cell Lung Cancer
Ghanem, P., Murray, J. C., Hsu, M., Guo, M. Z., Ettinger, D. S., Feliciano, J., Forde, P., Hann, C. L., Lam, V. K., Levy, B., Anagnostou, V., Brahmer, J. R. & Marrone, K. A., Mar 2024, In: Clinical lung cancer. 25, 2, p. 109-118 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical features and outcomes of advanced HER2+ esophageal/GEJ cancer with brain metastasis
Liang, K-L., Feliciano, J. L., Marrone, K. A., Murray, J. C., Hann, C. L., Anagnostou, V., Tackett, S. A., Shin, E. J., Hales, R. K., Voong, K. R., Battafarano, R. J., Yang, S. C., Broderick, S. R., Ha, J. S., Forde, P. M., Brahmer, J. R. & Lam, V. K., Jan 2024, In: ESMO Open. 9, 1, 102199.Research output: Contribution to journal › Article › peer-review
Open Access -
2023
Co-targeting BCL-XL and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in mice
Khan, S., Kellish, P., Connis, N., Thummuri, D., Wiegand, J., Zhang, P., Zhang, X., Budamagunta, V., Hua, N., Yang, Y., De, U., Jin, L., Zhang, W., Zheng, G., Hromas, R., Hann, C., Zajac-Kaye, M., Kaye, F. J. & Zhou, D., Dec 2023, In: Cell Death Discovery. 9, 1, 1.Research output: Contribution to journal › Article › peer-review
Open Access -
Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer
Sivapalan, L., Iams, W. T., Belcaid, Z., Scott, S. C., Niknafs, N., Balan, A., White, J. R., Kopparapu, P., Cann, C., Landon, B. V., Pereira, G., Velculescu, V. E., Hann, C. L., Lovly, C. M. & Anagnostou, V., Jun 13 2023, In: Clinical cancer research : an official journal of the American Association for Cancer Research. 29, 12, p. 2310-2323 14 p.Research output: Contribution to journal › Editorial › peer-review
Open Access -
Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer
Rudin, C. M., Reck, M., Johnson, M. L., Blackhall, F., Hann, C. L., Yang, J. C. H., Bailis, J. M., Bebb, G., Goldrick, A., Umejiego, J. & Paz-Ares, L., Dec 2023, In: Journal of Hematology and Oncology. 16, 1, 66.Research output: Contribution to journal › Review article › peer-review
Open Access -
Improved lung cancer clinical outcomes in patients with autoimmune rheumatic diseases
Ghanem, P., Murray, J. C., Marrone, K. A., Scott, S. C., Feliciano, J. L., Lam, V. K., Hann, C. L., Ettinger, D. S., Levy, B. P., Forde, P. M., Shah, A. A., Mecoli, C., Brahmer, J. & Cappelli, L. C., Oct 31 2023, In: RMD Open. 9, 4, e003471.Research output: Contribution to journal › Article › peer-review
Open Access -
Persistent mutation burden drives sustained anti-tumor immune responses
Niknafs, N., Balan, A., Cherry, C., Hummelink, K., Monkhorst, K., Shao, X. M., Belcaid, Z., Marrone, K. A., Murray, J., Smith, K. N., Levy, B., Feliciano, J., Hann, C. L., Lam, V., Pardoll, D. M., Karchin, R., Seiwert, T. Y., Brahmer, J. R., Forde, P. M., Velculescu, V. E., & 1 others, Feb 2023, In: Nature medicine. 29, 2, p. 440-449 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline
Khurshid, H., Ismaila, N., Bian, J., Dabney, R., Das, M., Ellis, P., Feldman, J., Hann, C., Kulkarni, S., Laskin, J., Manochakian, R., Mishra, D. R., Preeshagul, I., Reddy, P., Saxena, A., Weinberg, F. & Kalemkerian, G. P., Dec 10 2023, In: Journal of Clinical Oncology. 41, 35, p. 5448-5472 25 p.Research output: Contribution to journal › Article › peer-review
-
2022
An Oncology Urgent Care Clinic for the Management of Immune-Related Adverse Events: A Descriptive Analysis
Liang, K. L., Tackett, S., Myers, S., Brahmer, J. R., Browner, I. S., Ettinger, D. S., Forde, P. M., Hales, R. K., Hann, C. L., Lam, V. K., Marrone, K. A., Patel, T., Peterson, V., Sagorsky, S., Turner, M., Voong, K. R., Naidoo, J. & Feliciano, J. L., Jun 2022, In: Current Oncology. 29, 6, p. 4342-4353 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer Immunotherapy
Hsu, M. L., Murray, J. C., Psoter, K. J., Zhang, J., Barasa, D., Brahmer, J. R., Ettinger, D. S., Forde, P. M., Hann, C. L., Lam, V. K., Levy, B., Marrone, K. A., Patel, T., Peterson, V., Sagorsky, S., Turner, M., Anagnostou, V., Naidoo, J. & Feliciano, J. L., Nov 2022, In: Oncologist. 27, 11, p. 971-981 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Corrigendum to: Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of navitoclax (Biomedical Chromatography, (2022), 36, 3, 10.1002/bmc.5289)
Scott, S. C., Anders, N. M., He, P., Hemingway, A., Gore, S. D., Hann, C. L. & Rudek, M. A., Jun 2022, In: Biomedical Chromatography. 36, 6, e5383.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Definitive Chemoradiation and Durvalumab Consolidation for Locally Advanced, Unresectable KRAS-mutated Non-Small Cell Lung Cancer
Guo, M. Z., Murray, J. C., Ghanem, P., Voong, K. R., Hales, R. K., Ettinger, D., Lam, V. K., Hann, C. L., Forde, P. M., Brahmer, J. R., Levy, B. P., Feliciano, J. L. & Marrone, K. A., Nov 2022, In: Clinical lung cancer. 23, 7, p. 620-629 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms
Yao, J., Bergsland, E., Aggarwal, R., Aparicio, A., Beltran, H., Crabtree, J. S., Hann, C. L., Ibrahim, T., Byers, L. A., Sasano, H., Umejiego, J. & Pavel, M., Nov 2022, In: Oncologist. 27, 11, p. 940-951 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapy
Hwang, M., Canzoniero, J. V., Rosner, S., Zhang, G., White, J. R., Belcaid, Z., Cherry, C., Balan, A., Pereira, G., Curry, A., Niknafs, N., Zhang, J., Smith, K. N., Sivapalan, L., Chaft, J. E., Reuss, J. E., Marrone, K., Murray, J. C., Li, Q. K., Lam, V., & 7 others, Jun 10 2022, In: Journal for immunotherapy of cancer. 10, 6, e004688.Research output: Contribution to journal › Article › peer-review
Open Access -
Report of the First International Symposium on NUT Carcinoma
French, C. A., Cheng, M. L., Hanna, G. J., DuBois, S. G., Chau, N. G., Hann, C. L., Storck, S., Salgia, R., Trucco, M., Tseng, J., Stathis, A., Piekarz, R., Lauer, U. M., Massard, C., Bennett, K., Coker, S., Tontsch-Grun, U., Sos, M. L., Liao, S., Wu, C. J., & 3 others, Jun 15 2022, In: Clinical Cancer Research. 28, 12, p. 2493-2505 13 p.Research output: Contribution to journal › Article › peer-review
-
Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open-label, dose escalation study
Cousin, S., Blay, J. Y., Garcia, I. B., de Bono, J. S., Le Tourneau, C., Moreno, V., Trigo, J., Hann, C. L., Azad, A. A., Im, S. A., Cassier, P. A., French, C. A., Italiano, A., Keedy, V. L., Plummer, R., Sablin, M. P., Hemming, M. L., Ferron-Brady, G., Wyce, A., Khaled, A., & 10 others, Mar 15 2022, In: International Journal of Cancer. 150, 6, p. 993-1006 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Sex-specific differences in immunogenomic features of response to immune checkpoint blockade
Scott, S. C., Shao, X. M., Niknafs, N., Balan, A., Pereira, G., Marrone, K. A., Lam, V. K., Murray, J. C., Feliciano, J. L., Levy, B. P., Ettinger, D. S., Hann, C. L., Brahmer, J. R., Forde, P. M., Karchin, R., Naidoo, J. & Anagnostou, V., Aug 3 2022, In: Frontiers in Oncology. 12, 945798.Research output: Contribution to journal › Article › peer-review
Open Access -
Validation of a rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of vistusertib
Scott, S. C., Anders, N. M., Scardina, M., Hann, C. L. & Rudek, M. A., Jan 20 2022, In: Journal of Pharmaceutical and Biomedical Analysis. 208, 114436.Research output: Contribution to journal › Article › peer-review
Open Access -
Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of navitoclax
Scott, S. C., Anders, N. M., He, P., Hemingway, A., Gore, S. D., Hann, C. L. & Rudek, M. A., Mar 2022, In: Biomedical Chromatography. 36, 3, e5289.Research output: Contribution to journal › Article › peer-review
-
2021
A Phase 1 Study Evaluating Rovalpituzumab Tesirine in Frontline Treatment of Patients With Extensive-Stage SCLC
Hann, C. L., Burns, T. F., Dowlati, A., Morgensztern, D., Ward, P. J., Koch, M. M., Chen, C., Ludwig, C., Patel, M., Nimeiri, H., Komarnitsky, P. & Camidge, D. R., Sep 2021, In: Journal of Thoracic Oncology. 16, 9, p. 1582-1588 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A phase I/II study of rovalpituzumab tesirine in delta-like 3—expressing advanced solid tumors
Mansfield, A. S., Hong, D. S., Hann, C. L., Farago, A. F., Beltran, H., Waqar, S. N., Hendifar, A. E., Anthony, L. B., Taylor, M. H., Bryce, A. H., Tagawa, S. T., Lewis, K., Niu, J., Chung, C. H., Cleary, J. M., Rossi, M., Ludwig, C., Valenzuela, R., Luo, Y. & Aggarwal, R., Dec 2021, In: npj Precision Oncology. 5, 1, 74.Research output: Contribution to journal › Article › peer-review
Open Access -
Association of severe lymphopenia and disease progression in unresectable locally advanced non-small cell lung cancer treated with definitive chemoradiation and immunotherapy
Friedes, C., Chakrabarti, T., Olson, S., Prichett, L., Brahmer, J. R., Forde, P. J., Voong, R. K., Marrone, K. A., Lam, V. K., Hann, C. L., Broderick, S. R., Battafarano, R. J., Ha, J. S., Bush, E. L., Yang, S. C., Hales, R. K. & Feliciano, J. L., Apr 2021, In: Lung Cancer. 154, p. 36-43 8 p.Research output: Contribution to journal › Article › peer-review
-
AZD8055 enhances in vivo efficacy of afatinib in chordomas
Zhao, T., Siu, I. M., Williamson, T., Zhang, H., Ji, C., Burger, P. C., Connis, N., Ruzevick, J., Xia, M., Cottone, L., Flanagan, A. M., Hann, C. L. & Gallia, G. L., Sep 2021, In: Journal of Pathology. 255, 1, p. 72-83 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Immunotherapy for small cell lung cancer: Established applications and novel approaches
Scott, S. C. & Hann, C. L., Oct 2021, In: Clinical Advances in Hematology and Oncology. 19, 10, p. 654-663 10 p.Research output: Contribution to journal › Article › peer-review
-
Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: Results of a phase 1 clinical trial
Gallia, G. L., Holdhoff, M., Brem, H., Joshi, A. D., Hann, C. L., Bai, R. Y., Staedtke, V., Blakeley, J. O., Sengupta, S., Jarrell, T. C., Wollett, J., Szajna, K., Helie, N., Mattox, A. K., Ye, X., Rudek, M. A. & Riggins, G. J., Jan 1 2021, In: Neuro-Oncology Advances. 3, 1, vdaa154.Research output: Contribution to journal › Article › peer-review
Open Access -
Nelfinavir inhibits the growth of small-cell lung cancer cells and patient-derived xenograft tumors
KAWABATA, SHIGERU., CONNIS, NICK., GILLS, JOELL. J., HANN, CHRISTINE. L. & DENNIS, PHILLIP. A., Jan 2021, In: Anticancer research. 41, 1, p. 91-99 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Phase IB study of osimertinib in combination with navitoclax in egfr-mutant nsclc following resistance to initial EGFR Therapy (ETCTN 9903)
Bertino, E. M., Gentzler, R. D., Clifford, S., Kolesar, J., Muzikansky, A., Haura, E. B., Piotrowska, Z., Ross Camidge, D., Stinchcombe, T. E., Hann, C., Malhotra, J., Villaruz, L. C., Paweletz, C. P., Lau, C. L., Sholl, L., Takebe, N., Moscow, J. A., Shapiro, G. I., Janne, P. A. & Oxnard, G. R., Mar 2021, In: Clinical Cancer Research. 27, 6, p. 1604-1611 8 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC
Reuss, J. E., Brigham, E., Psoter, K. J., Voong, K. R., Shankar, B., Ettinger, D. S., Marrone, K. A., Hann, C. L., Levy, B., Feliciano, J. L., Brahmer, J. R., Feller-Kopman, D., Lerner, A. D., Lee, H., Yarmus, L., Hales, R. K., D'Alessio, F., Danoff, S. K., Forde, P. M., Suresh, K., & 1 others, Oct 2021, In: JTO Clinical and Research Reports. 2, 10, 100220.Research output: Contribution to journal › Article › peer-review
Open Access -
Small Cell Lung Cancer: Biology Advances
Hann, C. L., 2021, Current Cancer Research. Springer Nature, p. 197-211 15 p. (Current Cancer Research).Research output: Chapter in Book/Report/Conference proceeding › Chapter
-
Small Cell Lung Cancer, Version 2.2022
Ganti, A. K. P., Loo, B. W., Bassetti, M., Blakely, C., Chiang, A., D'Amico, T. A., D'Avella, C., Dowlati, A., Downey, R. J., Edelman, M., Florsheim, C., Gold, K. A., Goldman, J. W., Grecula, J. C., Hann, C., Iams, W., Iyengar, P., Kelly, K., Khalil, M., Koczywas, M., & 14 others, Dec 2021, In: JNCCN Journal of the National Comprehensive Cancer Network. 19, 12, p. 1441-1464 24 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Steroid-refractory PD-(L)1 pneumonitis: Incidence, clinical features, treatment, and outcomes
Balaji, A., Hsu, M., Lin, C. T., Feliciano, J., Marrone, K., Brahmer, J. R., Forde, P. M., Hann, C., Zheng, L., Lee, V., Illei, P. B., Danoff, S. K., Suresh, K. & Naidoo, J., Jan 7 2021, In: Journal for immunotherapy of cancer. 9, 1, e001731.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
2020
Expression of Programmed Cell Death Ligand 1 and Associated Lymphocyte Infiltration in Olfactory Neuroblastoma
London, N. R., Rooper, L. M., Bishop, J. A., Xu, H., Bernhardt, L. J., Ishii, M., Hann, C. L., Taube, J. M., Izumchenko, E., Gaykalova, D. A. & Gallia, G. L., Mar 2020, In: World neurosurgery. 135, p. e187-e193Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Lung cancer and family-centered concerns
Feliciano, J., Chang, A., Venkatraman, D., Brooks, S., Zagaja, C., Ettinger, D., Hann, C., Naidoo, J., Voong, R., Hales, R., Turner, M., Peterson, V. & Bodurtha, J., Feb 1 2020, In: Supportive Care in Cancer. 28, 2, p. 497-505 9 p.Research output: Contribution to journal › Article › peer-review
-
Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer
Anagnostou, V., Niknafs, N., Marrone, K., Bruhm, D. C., White, J. R., Naidoo, J., Hummelink, K., Monkhorst, K., Lalezari, F., Lanis, M., Rosner, S., Reuss, J. E., Smith, K. N., Adleff, V., Rodgers, K., Belcaid, Z., Rhymee, L., Levy, B., Feliciano, J., Hann, C. L., & 15 others, Jan 1 2020, In: Nature Cancer. 1, 1, p. 99-111 13 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Multisystem Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung Cancer
Shankar, B., Zhang, J., Naqash, A. R., Forde, P. M., Feliciano, J. L., Marrone, K. A., Ettinger, D. S., Hann, C. L., Brahmer, J. R., Ricciuti, B., Owen, D., Toi, Y., Walker, P., Otterson, G. A., Patel, S. H., Sugawara, S. & Naidoo, J., Dec 2020, In: JAMA Oncology. 6, 12, p. 1952-1956 5 p.Research output: Contribution to journal › Article › peer-review
Open Access11 Scopus citations -
New Approaches to SCLC Therapy: From the Laboratory to the Clinic
Poirier, J. T., George, J., Owonikoko, T. K., Berns, A., Brambilla, E., Byers, L. A., Carbone, D., Chen, H. J., Christensen, C. L., Dive, C., Farago, A. F., Govindan, R., Hann, C., Hellmann, M. D., Horn, L., Johnson, J. E., Ju, Y. S., Kang, S., Krasnow, M., Lee, J., & 27 others, Apr 2020, In: Journal of Thoracic Oncology. 15, 4, p. 520-540 21 p.Research output: Contribution to journal › Review article › peer-review
Open Access18 Scopus citations -
Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort
Ready, N. E., Ott, P. A., Hellmann, M. D., Zugazagoitia, J., Hann, C. L., de Braud, F., Antonia, S. J., Ascierto, P. A., Moreno, V., Atmaca, A., Salvagni, S., Taylor, M., Amin, A., Camidge, D. R., Horn, L., Calvo, E., Li, A., Lin, W. H., Callahan, M. K. & Spigel, D. R., Mar 2020, In: Journal of Thoracic Oncology. 15, 3, p. 426-435 10 p.Research output: Contribution to journal › Article › peer-review
Open Access54 Scopus citations -
Phase 1 study of molibresib (GSK525762), a bromodomain and extra-terminal domain protein inhibitor, in NUT carcinoma and other solid tumors
Piha-Paul, S. A., Hann, C. L., French, C. A., Cousin, S., Braña, I., Cassier, P. A., Moreno, V., de Bono, J. S., Harward, S. D., Ferron-Brady, G., Barbash, O., Wyce, A., Wu, Y., Horner, T., Annan, M., Parr, N. J., Prinjha, R. K., Carpenter, C. L., Hilton, J., Hong, D. S., & 5 others, 2020, In: JNCI Cancer Spectrum. 4, 2, PKZ093.Research output: Contribution to journal › Article › peer-review
Open Access28 Scopus citations -
2019
Dynamics of tumor and immune responses during immune checkpoint blockade in non–small cell lung cancer
Anagnostou, V., Forde, P. M., White, J. R., Niknafs, N., Hruban, C., Naidoo, J., Marrone, K., Ashok Sivakumar, I. K., Bruhm, D. C., Rosner, S., Phallen, J., Leal, A., Adleff, V., Smith, K. N., Cottrell, T. R., Rhymee, L., Palsgrove, D. N., Hann, C. L., Levy, B., Feliciano, J., & 16 others, 2019, In: Cancer Research. 79, 6, p. 1214-1225 12 p.Research output: Contribution to journal › Article › peer-review
Open Access61 Scopus citations -
Efficacy and safety of rovalpituzumab tesirine in third-line and beyond patients with DLL3-expressing, relapsed/refractory small-cell lung cancer: Results from the phase II TrINITY study
Morgensztern, D., Besse, B., Greillier, L., Santana-Davila, R., Ready, N., Hann, C. L., Glisson, B. S., Farago, A. F., Dowlati, A., Rudin, C. M., Le Moulec, S., Lally, S., Yalamanchili, S., Wolf, J., Govindan, R. & Carbone, D. P., Dec 1 2019, In: Clinical Cancer Research. 25, 23, p. 6958-6966 9 p.Research output: Contribution to journal › Article › peer-review
Open Access63 Scopus citations -
Griseofulvin Radiosensitizes Non–Small Cell Lung Cancer Cells and Activates cGAS
Wang, X., Raman, N., Lemtiri-Chlieh, G., Chang, J., Jagtap, S., Chowdhury, D. D., Ballew, M., Carrieri, F. A., Nguyen, T., Nugent, K., Peck, T., Levine, M. S., Chan, A., Lam, C., Malek, R., Hoang, T., Phillips, R., Cheng, Z. A., Taparra, K., Connis, N., & 5 others, Apr 1 2019, In: Molecular cancer therapeutics. 22, 4, p. 519-528 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy
Suresh, K., Psoter, K. J., Voong, K. R., Shankar, B., Forde, P. M., Ettinger, D. S., Marrone, K. A., Kelly, R. J., Hann, C. L., Levy, B., Feliciano, J. L., Brahmer, J. R., Feller-Kopman, D., Lerner, A. D., Lee, H., Yarmus, L., Hales, R. K., D'Alessio, F., Danoff, S. K. & Naidoo, J., Mar 2019, In: Journal of Thoracic Oncology. 14, 3, p. 494-502 9 p.Research output: Contribution to journal › Article › peer-review
Open Access43 Scopus citations -
Relationship Between Prior Radiotherapy and Checkpoint-Inhibitor Pneumonitis in Patients With Advanced Non–Small-Cell Lung Cancer
Voong, K. R., Hazell, S. Z., Fu, W., Hu, C., Lin, C. T., Ding, K., Suresh, K., Hayman, J., Hales, R. K., Alfaifi, S., Marrone, K. A., Levy, B., Hann, C. L., Ettinger, D. S., Feliciano, J. L., Peterson, V., Kelly, R. J., Brahmer, J. R., Forde, P. M. & Naidoo, J., Jul 2019, In: Clinical lung cancer. 20, 4, p. e470-e479Research output: Contribution to journal › Article › peer-review
Open Access25 Scopus citations -
The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis
Suresh, K., Naidoo, J., Zhong, Q., Xiong, Y., Mammen, J., De Flores, M. V., Cappelli, L., Balaji, A., Palmer, T., Forde, P. M., Anagnostou, V., Ettinger, D. S., Marrone, K. A., Kelly, R. J., Hann, C. L., Levy, B., Feliciano, J. L., Lin, C. T., Feller-Kopman, D., Lerner, A. D., & 8 others, Oct 1 2019, In: Journal of Clinical Investigation. 129, 10, p. 4305-4315 11 p.Research output: Contribution to journal › Article › peer-review
Open Access28 Scopus citations -
Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032
Ready, N., Farago, A. F., de Braud, F., Atmaca, A., Hellmann, M. D., Schneider, J. G., Spigel, D. R., Moreno, V., Chau, I., Hann, C. L., Eder, J. P., Steele, N. L., Pieters, A., Fairchild, J. & Antonia, S. J., Feb 2019, In: Journal of Thoracic Oncology. 14, 2, p. 237-244 8 p.Research output: Contribution to journal › Article › peer-review
Open Access120 Scopus citations -
2018
A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy-Naïve Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer
Marrone, K. A., Zhou, X., Forde, P. M., Purtell, M., Brahmer, J. R., Hann, C. L., Kelly, R. J., Coleman, B., Gabrielson, E., Rosner, G. L. & Ettinger, D. S., Jul 2018, In: Oncologist. 23, 7, p. 859-865 7 p.Research output: Contribution to journal › Article › peer-review
Open Access32 Scopus citations -
Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma
Gallia, G. L., Zhang, M., Ning, Y., Haffner, M. C., Batista, D., Binder, Z. A., Bishop, J. A., Hann, C. L., Hruban, R. H., Ishii, M., Klein, A. P., Reh, D. D., Rooper, L. M., Salmasi, V., Tamargo, R. J., Wang, Q., Williamson, T., Zhao, T., Zou, Y., Meeker, A. K., & 5 others, Dec 1 2018, In: Nature communications. 9, 1, 5410.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Lung and Thymic Carcinoids
Hann, C. & Forde, P., Sep 1 2018, In: Endocrinology and Metabolism Clinics of North America. 47, 3, p. 699-709 11 p.Research output: Contribution to journal › Review article › peer-review
5 Scopus citations -
NCCN guidelines® insights: Small cell lung cancer, version 2.2018 featured updates to the NCCN guidelines
Kalemkerian, G. P., Loo, B. W., Akerley, W., Attia, A., Bassetti, M., Boumber, Y., Decker, R., Dobelbower, M. C., Dowlati, A., Downey, R. J., Florsheim, C., Ganti, A. K. P., Grecula, J. C., Gubens, M. A., Hann, C. L., Hayman, J. A., Heist, R. S., Koczywas, M., Merritt, R. E., Mohindra, N., & 11 others, Oct 1 2018, In: JNCCN Journal of the National Comprehensive Cancer Network. 16, 10, p. 1171-1182 12 p.Research output: Contribution to journal › Article › peer-review
Open Access76 Scopus citations -
Pneumonitis in Non–Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors
Suresh, K., Voong, K. R., Shankar, B., Forde, P. M., Ettinger, D. S., Marrone, K. A., Kelly, R. J., Hann, C. L., Levy, B., Feliciano, J. L., Brahmer, J. R., Feller-Kopman, D., Lerner, A. D., Lee, H., Yarmus, L., D'Alessio, F., Hales, R. K., Lin, C. T., Psoter, K. J., Danoff, S. K., & 1 others, Dec 2018, In: Journal of Thoracic Oncology. 13, 12, p. 1930-1939 10 p.Research output: Contribution to journal › Article › peer-review
107 Scopus citations